Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Biodesix, Inc. (BDSX) vs Burning Rock Biotech Limited Sponsored ADR (BNR)

Biodesix, Inc. and Burning Rock Biotech Limited Sponsored ADR are both Diagnostics & Research companies. Biodesix, Inc. is the larger, with a market value of $310.2M against $158.2M — 2.0× the size. Biodesix, Inc. grew revenue faster over the last twelve months: 34.5% against −0.14%. Burning Rock Biotech Limited Sponsored ADR has the higher net margin (−13.5% vs −27.0%) and the lower return on invested capital (−50.7% vs −49.6%). Across the 18 metrics below, Burning Rock Biotech Limited Sponsored ADR leads on 11 and Biodesix, Inc. on 7.

Valuation

Metric BDSX BNR Diagnostics & Research median
P/E n/m n/m 33.95
P/S 2.91 27.45 4.87
P/B 32.77 27.57 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales 3.07 26.61 5.66
Earnings yield (10.89%) (2.79%) (1.75%)
Free cash flow yield (6.81%) (0.72%) (0.13%)

Profitability

Metric BDSX BNR Diagnostics & Research median
Gross margin 82.50% 74.50% 50.89%
Operating margin (20.02%) (12.95%) (8.57%)
Net margin (26.97%) (13.51%) (6.37%)
Free cash flow margin (19.82%) (3.00%) 0.00%
Return on equity (540.01%) (13.08%) (2.92%)
Return on assets (30.33%) (8.81%) (6.71%)
Return on invested capital (49.60%) (50.66%) 0.00%

Growth

Metric BDSX BNR Diagnostics & Research median
Revenue growth (TTM) 34.46% (0.14%) 7.69%
EPS growth (last fiscal year) 29.24% 84.16% —
Revenue growth, 5-year CAGR 14.20% 3.21% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDSX BNR Diagnostics & Research median
Debt to equity 5.12 0.00 0.11
Current ratio 2.85 3.05 2.02
Net debt to EBITDA (1.36) 14.48 0.78

Dividend

Metric BDSX BNR Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric BDSX BNR Diagnostics & Research median
Market cap 310.20m 158.22m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack